Free Trial

Canopy Growth (TSE:WEED) Trading Up 3.6% - Here's What Happened

Canopy Growth logo with Medical background
Remove Ads

Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price was up 3.6% on Tuesday . The company traded as high as C$1.89 and last traded at C$1.74. Approximately 679,652 shares changed hands during mid-day trading, a decline of 56% from the average daily volume of 1,532,193 shares. The stock had previously closed at C$1.68.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on WEED shares. Canaccord Genuity Group decreased their price target on Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating for the company in a research report on Monday, February 10th. ATB Capital reduced their price objective on Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating for the company in a research note on Monday, February 10th. Four research analysts have rated the stock with a sell rating and one has given a hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Reduce" and a consensus target price of C$5.64.

View Our Latest Research Report on WEED

Canopy Growth Price Performance

The stock has a 50 day moving average price of C$2.48 and a two-hundred day moving average price of C$4.49. The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39. The company has a market capitalization of C$260.61 million, a PE ratio of -0.24, a P/E/G ratio of -0.01 and a beta of 1.79.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Further Reading

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads